Study of a Respiratory Syncytial Virus Candidate Formulation in Adults Aged 60 Years and Older

PHASE2CompletedINTERVENTIONAL
Enrollment

4,541

Participants

Timeline

Start Date

April 2, 2024

Primary Completion Date

March 11, 2025

Study Completion Date

March 11, 2025

Conditions
Respiratory Syncytial Virus InfectionHealthy Volunteers
Interventions
BIOLOGICAL

RSV vaccine candidate

Pharmaceutical form:Suspension for injection-Route of administration:Intramuscular Injection

BIOLOGICAL

Placebo

Pharmaceutical form:Suspension for injection-Route of administration:Intramuscular Injection

Trial Locations (25)

2019

Investigational Site Number : 0360003, Botany

3124

Investigational Site Number : 0360002, Camberwell

4222

Investigational Site Number : 0360001, Southport

4556

Investigational Site Number : 0360004, Sippy Downs

5067

Investigational Site Number : 0360005, Norwood

10205

Investigational Site Number : 2140001, Santo Domingo

Investigational Site Number : 2140002, Santo Domingo

11101

Investigational Site Number : 3400003, Tegucigalpa

Investigational Site Number : 3400002, Tegucugalpa

21104

Investigational Site Number : 3400001, San Pedro Sula

37000

Investigational Site Number : 4840002, León

76001

Investigational Site Number : 1700007, Santiago de Cali

76100

Investigational Site Number : 4840003, Querétaro

110111

Investigational Site Number : 1700006, Bogotá

252431

Investigational Site Number : 1700003, Girardot

630001

Investigational Site Number : 1700001, Quindío

730001

Investigational Site Number : 1700005, Ibagué

856010

Investigational Site Number : 1700004, Aguazul

4070094

Investigational Site Number : 1520006, Concepción

7500657

Investigational Site Number : 1520002, Santiago

7510157

Investigational Site Number : 1520008, Santiago

7580206

Investigational Site Number : 1520005, Santiago

8380453

Investigational Site Number : 1520001, Santiago

8420383

Investigational Site Number : 1520004, Santiago

080020

Investigational Site Number : 1700002, Barranquilla

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT06251024 - Study of a Respiratory Syncytial Virus Candidate Formulation in Adults Aged 60 Years and Older | Biotech Hunter | Biotech Hunter